2 results
Approved WMOCompleted
To prospectively test for superiority of atogepant 60 mg QD versus placebo for the prevention of migraine in participants with episodic migraine who have previously failed 2 to 4 classes of oral medications for the prophylaxis of migraine
Approved WMOCompleted
Long-term safety and pharmacokinetics (PK) of neoGAA